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The Lyon laboratory focuses on analyzing human genetic variation and understanding how 
genetic mutations contribute to severe idiopathic neuropsychiatric disorders. We do this by 
studying large pedigrees living in the same geographic location, where one can study the 
expressivity and segregation of variants in a similar environmental background and with fewer 
population stratification concerns. Toward this end, we collect pedigrees in Utah and elsewhere, 
and then utilize exome and whole genome sequencing to find mutations that segregate with 
syndromes in the pedigrees. We focus on the discovery of families with rare diseases and/or 
increased prevalence for syndromes such as intellectual disability, autism and schizophrenia. 
Once we identify mutations that likely contribute to a disease, we undertake detailed functional 
studies of these mutations and the biological processes affected. Several projects are still at an 
early stage, but some of the projects that are sufficiently far enough along to discuss publicly 
are listed below. 
 
Ogden Syndrome and the Amino-terminal acetylation of proteins 
with Max Doerfel, Yiyang Wu, Ronen Marmorstein (Philadelphia, PA), Thomas Arnesen 
(Norway), Nathalie Reuter (Norway), Petra van Damme (Belgium) 
 
We have previously identified a lethal X-linked disorder of infancy comprising a distinct 
combination of distinctive craniofacial features producing an aged appearance, growth failure, 
hypotonia, global developmental delays, cryptorchidism, and acquired cardiac arrhythmias. The 
first family was identified in Ogden, Utah, with five affected boys in two generations of family 
members.  A mutation was identified as a c.109T>C (p.Ser37Pro) variant in NAA10, a gene 
encoding the catalytic subunit of the major human N-terminal acetyltransferase (NatA). This 
same mutation was identified in a second unrelated family, with three affected boys in two 
generations. This X-linked Malformation and Infantile Lethality Syndrome has been named 
Ogden Syndrome, in honor of the hometown where the first family resides. This is the first 
human disease involving a defect in the N-terminal acetylation of proteins, a common (yet vastly 
understudied) modifications of eukaryotic proteins carried out by N-terminal acetyltransferases 
(NATs). There is significantly impaired biochemical activity of the mutant hNaa10p, suggesting 
that a reduction in acetylation of some unidentified proteins by hNaa10p might lead to this 
disease. There is currently very limited knowledge on the functional importance of Nt-acetylation 
at the protein level and at the organismal level.  
In order to understand the detrimental impact of the Naa10 S37P mutation, we 
performed structural, molecular and cellular investigations. The recently determined S. pombe 
NatA complex crystal structure was used as a template to generate a model of human NatA, 
revealing a highly conserved complex. The model allowed for comparison of Naa10 wt and 
Naa10 S37P within the NatA complex and suggested a decreased flexibility for Naa10 S37P in 
regions involved in catalysis and at the interface with the auxiliary subunit Naa15. The hydrogen 
bonding network between Naa10 and Naa15 was also rearranged. In vitro enzyme kinetics of 
Naa10 S37P demonstrated a reduced catalytic capacity, probably due to impaired peptide 
substrate binding. In agreement with the structural model, Naa10 S37P displayed a reduced 
capacity to form a stable NatA complex. N-terminal acetylome analyses of patient B-cells and 
fibroblasts provided a survey of Nt-acetylation in human non-cancer cells. In line with previous 
NatA knockdown data, patient derived S37P B-cells and fibroblasts have reduced Nt-acetylation 
for a subset of NatA-type substrates compared to cells from healthy family members, 
demonstrating in vivo perturbation of Naa10 (NatA) mediated Nt-acetylation in Ogden syndrome 
males. THOC7, one of the affected proteins, was shown to depend on Nt-acetylation for its 
stability. Ogden syndrome fibroblasts further displayed abnormal cell proliferation and migration 
capacity. Therefore, the Ogden syndrome mutant Naa10 is impaired in NatA complex formation 
and catalytic capacity, and patient cells display reduced in vivo Nt-acetylation and cellular 
phenotypes potentially linked to the defects observed in the males suffering from this disease. 
 
 
Low concordance of multiple variant-calling pipelines, practical implications for exome and 
genome sequencing 
with Jason O’Rawe, Kai Wang (Los Angeles, California) 
 
To facilitate the clinical implementation of genomic medicine by next-generation sequencing, it 
will be critically important to obtain accurate and consistent variant calls on personal genomes. 
Multiple software tools for variant calling are available, but it is unclear how comparable these 
tools are or what their relative merits in real-world scenarios might be. We sequenced 15 
exomes from four families using commercial kits (Illumina HiSeq 2000 platform and Agilent 
SureSelect version 2 capture kit), with approximately 120X mean coverage. We analyzed the 
raw data using near-default parameters with five different alignment and variant-calling pipelines 
(SOAP, BWA-GATK, BWA-SNVer, GNUMAP, and BWA-SAMtools). We additionally sequenced 
a single whole genome using the sequencing and analysis pipeline from Complete Genomics 
(CG), with 95% of the exome region being covered by 20 or more reads per base. Finally, we 
validated 919 single-nucleotide variations (SNVs) and 841 insertions and deletions (indels), 
including similar fractions of GATK-only, SOAP-only, and shared calls, on the MiSeq platform by 
amplicon sequencing with approximately 5000X mean coverage.SNV concordance between five 
Illumina pipelines across all 15 exomes was 57.4%, while 0.5 to 5.1% of variants were called as 
unique to each pipeline. Indel concordance was only 26.8% between three indel-calling 
pipelines, even after left-normalizing and intervalizing genomic coordinates by 20 base pairs. 
There were 11% of CG variants falling within targeted regions in exome sequencing that were 
not called by any of the Illumina-based exome analysis pipelines. Based on targeted amplicon 
sequencing on the MiSeq platform, 97.1%, 60.2%, and 99.1% of the GATK-only, SOAP-only 
and shared SNVs could be validated, but only 54.0%, 44.6%, and 78.1% of the GATK-only, 
SOAP-only and shared indels could be validated. Additionally, our analysis of two families (one 
with four individuals and the other with seven), demonstrated additional accuracy gained in 
variant discovery by having access to genetic data from a multi-generational family. Our results 
suggest that more caution should be exercised in genomic medicine settings when analyzing 
individual genomes, including interpreting positive and negative findings with scrutiny, especially 
for indels. We advocate for renewed collection and sequencing of multi-generational families to 
increase the overall accuracy of whole genomes. 
 
Advancing precision medicine through clinical grade whole genome sequencing, return 
of results, and neuromodulation. 
with Jason O’Rawe, Han Fang, Martin Reese (California), Gerry Higgins (Washington, D.C.), 
Karen Eilbeck (Utah), Reid Robison (Utah) 
 
 For widespread precision medicine to become a reality, many things must be optimized, 
including clinical-grade sample collection, high-quality sequencing data acquisition, digitalized 
phenotyping, rigorous generation of variant calls, and online sharing of medical history and 
genomic data with research participants and others. We report the detailed phenotypic 
characterization, clinical-grade whole genome sequencing (WGS), and two-year outcome of a 
man with severe obsessive compulsive disorder (OCD) treated with deep brain stimulation 
(DBS) of the nucleus accumbens / anterior limb of the internal capsule. As part of his integrated 
medical care, his genome was sequenced and variants detected in the Illumina WGS Clinical 
Laboratory Improvement Amendments (CLIA)-certified laboratory. It is increasingly apparent 
that mental illness results from a constellation of genetic and environmental factors, and, 
consistent with this, WGS did not reveal any one mutation of large effect, but instead showed 
that he carries several alleles that have been shown to elevate risk for mental illness.  This 
includes the p.Val66Met variant in brain derived neurotrophic factor (BDNF), the p.Glu429Ala 
allele in methylenetetrahydrofolate reductase (MTHFR), and the p.Asp7Asn allele in choline O-
acetyltransferase (ChAT). We identified thousands of other variants in his genome, including 
pharmacogenetic variants, and one mutation led to the discovery that he has untreated bilateral 
cataracts and other visual disturbances. We archived all data in the GVFclin format and also 
returned many results to this person. Since implantation of the deep brain stimulator, this man 
has reported steady improvement, highlighted by a decline in his Yale-Brown Obsessive 
Compulsive Scale (YBOCS) score from ~38 to a score of ~25. A rechargeable Activa RC 
neurostimulator battery has been of major benefit in terms of facilitating a degree of stability and 
control over the stimulation. His psychiatric symptoms reliably worsen within hours of the battery 
becoming depleted, thus providing confirmatory evidence for the efficacy of DBS for OCD in this 
person. To our knowledge, this was the first study in the clinical neurosciences that integrates 
detailed neuropsychiatric phenotyping, deep brain stimulation for OCD and clinical-grade WGS, 
with management and the first return of WGS results to a person with severe mental illness.  
 
The Characterization and Analysis of an Idiopathic Intellectual Disability Syndrome via 
Whole Genome Sequencing Analysis 
with Jason O’Rawe, Yiyang Wu, Alan Rope and Jeffrey Swensen (University of Utah),  
 
We continued this year to study a new idiopathic syndrome with intellectual disability and 
distinctive facial dysmorphology. The propositi are two affected male brothers, aged 10 and 12 
respectively, with severe intellectual disability, autism-like behavior, attention deficit issues, and 
very distinctive facial features, including broad, upturned nose, sagging cheeks, downward 
sloping palpebral fissures, relative hypertelorism, high-arched palate, and prominent ears. Their 
parents are nonconsanguineous and are both healthy, and the family history does not 
demonstrate any other members with anything resembling this current syndrome. X-
chromosome inactivation assays reveal skewing in the mother, suggesting the possibility of an 
X-linked disorder. High-density genotyping arrays in the mother, father and two sons have not 
revealed previously known copy number variants (CNVs) that might contribute to the phenotype.  
Whole genome sequencing has led to the identification of several rare variants that are currently 
being characterized further, including in other unaffected members of the extended family. 
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